Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 18 (3) , 651-668
- https://doi.org/10.1016/j.idc.2004.04.014
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Delayed Discovery of Linezolid‐Resistant, Vancomycin‐ResistantEnterococcus faecium:Lessons LearnedClinical Infectious Diseases, 2004
- Analysis of Daptomycin Efficacy and Breakpoint Standards in a Murine Model ofEnterococcus faecalisandEnterococcus faeciumRenal InfectionAntimicrobial Agents and Chemotherapy, 2003
- Hematologic Effects of Linezolid: Summary of Clinical ExperienceAntimicrobial Agents and Chemotherapy, 2002
- In vitro Activity of Quinupristin/ Dalfopristin, RP59500, against Gram-Positive Clinical IsolatesChemotherapy, 1997
- Emergence of vancomycin-resistant enterococci in New York CityThe Lancet, 1993
- Clinical Pharmacokinetics of VancomycinClinical Pharmacokinetics, 1986
- Vancomycin for Treatment of Bacterial MeningitisClinical Infectious Diseases, 1981
- Pharmacokinetics of Vancomycin in AnuriaClinical Infectious Diseases, 1981
- Structural Features of VancomycinClinical Infectious Diseases, 1981
- Peritoneal Transport of Vancomycin during Peritoneal DialysisNephron, 1979